What is the price of a box of serpotinib/serpatinib on the market in 2025?
Selpercatinib is a new type of targeted therapy drug mainly used to treat non-small cell lung cancer (NSCLC) with RET gene rearrangement and other related tumors. The drug effectively prevents the growth and spread of tumor cells by selectively inhibiting the activity of RET kinase, thereby providing new treatment options for patients with these specific types of cancer.
In the Chinese market, the original drug of Seputinib has been officially launched in the packaging format of 80mg*56 capsules. According to the current market conditions, its price is expected to exceed 10,000 yuan, which is a considerable expense for many patients. It should be noted that since this drug has not yet been included in the national medical insurance catalog, patients need to bear the full cost when purchasing it, which undoubtedly increases the financial burden.
At the same time, in overseas markets, Septinib has also received widespread attention. The price of original research drugs in Europe and the United States is relatively high, generally ranging from 20,000 to more than 100,000 yuan. This price fluctuation is mainly affected by exchange rate changes. In this context, when patients consider the source of drugs, they often also pay attention to the availability and economy of overseas medical resources.
It is worth mentioning that some generic drugs of Seputinib have appeared on the market. The ingredients of these generic drugs are basically the same as those of the original drugs at home and abroad, which can provide patients with a more economical choice. For example, the generic version of Seputinib produced by a Lao pharmaceutical factory is 40mg*120 pills per box, and the price may be more than 2,000 yuan, which is obviously a more affordable treatment option. However, when choosing to use generic drugs, patients still need to carefully consider their quality and related certifications to ensure the safety and effectiveness of the treatment.
Reference:https://en.wikipedia.org/wiki/Selpercatinib
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)